Matrix-Immobilized BMP-2 on Microcontact Printed Fibronectin as an in vitro Tool to Study BMP-Mediated Signaling and Cell Migration by Kristin Hauff et al.
ORIGINAL RESEARCH
published: 11 May 2015
doi: 10.3389/fbioe.2015.00062
Edited by:
Anna Lagunas,
Instituto de Salud Carlos III, Spain
Reviewed by:
Claudio G. Rolli,
Weizmann Institute of Science, Israel
Boaz Mizrahi,
Technion – Israel Institute of
Technology, Israel
Kevin Shakesheff,
University of Nottingham, UK
*Correspondence:
Elisabetta Ada Cavalcanti-Adam,
Institute of Physical Chemistry,
University of Heidelberg, Im
Neuenheimer Feld 253, Heidelberg
69120, Germany
ada.cavalcanti-adam@
urz.uni-heidelberg.de
Specialty section:
This article was submitted to
Biomaterials, a section of the journal
Frontiers in Bioengineering and
Biotechnology
Received: 13 February 2015
Accepted: 20 April 2015
Published: 11 May 2015
Citation:
Hauff K, Zambarda C, Dietrich M,
Halbig M, Grab AL, Medda R and
Cavalcanti-Adam EA (2015)
Matrix-immobilized BMP-2 on
microcontact printed fibronectin as an
in vitro tool to study BMP-mediated
signaling and cell migration.
Front. Bioeng. Biotechnol. 3:62.
doi: 10.3389/fbioe.2015.00062
Matrix-immobilized BMP-2 on
microcontact printed fibronectin as
an in vitro tool to study
BMP-mediated signaling and cell
migration
Kristin Hauff 1,2, Chiara Zambarda 1,3, Miriam Dietrich 1, Maria Halbig 1,3, Anna Luise Grab 1,
Rebecca Medda 1,3 and Elisabetta Ada Cavalcanti-Adam 1,3*
1 Department of Biophysical Chemistry, Institute of Physical Chemistry, University of Heidelberg, Heidelberg,
Germany, 2 Applied Chemistry, University of Reutlingen, Reutlingen, Germany, 3 Department of New Materials and
Biosystems, Max Planck Institute for Intelligent Systems, Stuttgart, Germany
During development, growth factors (GFs) such as bone morphogenetic proteins (BMPs)
exert important functions in several tissues by regulating signaling for cell differentiation
and migration. In vivo, the extracellular matrix (ECM) not only provides support for
adherent cells, but also acts as reservoir of GFs. Several constituents of the ECM provide
adhesive cues, which serve as binding sites for cell trans-membrane receptors, such
as integrins. In conveying adhesion-mediated signaling to the intracellular compartment,
integrins do not function alone but rather crosstalk and cooperate with other receptors,
such as GF receptors. Here, we present a strategy for the immobilization of BMP-2
onto cellular fibronectin (cFN), a key protein of the ECM, to investigate GF-mediated
signaling and migration. Following biotinylation, BMP-2 was linked to biotinylated cFN
using NeutrAvidin as cross-linker. Characterization with quartz crystal microbalance with
dissipation monitoring and enzyme-linked immunosorbent assay confirmed the efficient
immobilization of BMP-2 on cFN over a period of 24 h. To validate the bioactivity of
matrix-immobilized BMP-2 (iBMP-2), we investigated short- and long-term responses
of C2C12 myoblasts, which are an established in vitro model for BMP-2 signaling, in
comparison to soluble BMP-2 (sBMP-2) or in absence of GFs. Similarly to sBMP-2,
iBMP-2 triggered Smad 1/5 phosphorylation and translocation of the complex to the
nucleus, corresponding to the activation of BMP-mediated Smad-dependent pathway.
Additionally, successful suppression of myotube formation was observed after 6 days
in sBMP-2 and iBMP-2. We next implemented this approach in the fabrication of cFN
micropatterned stripes by soft lithography. These stripes allowed cell-surface interaction
only on the patterned cFN, since the surface in between was passivated, thus serving
as platform for studies on directed cell migration. During a 10-h observation time, the
migratory behavior, especially the cells’ net displacement, was increased in presence
of BMP-2. As such, this versatile tool retains the bioactivity of GFs and allows the
presentation of ECM adhesive cues.
Keywords: BMP-2, fibronectin, microcontact printing, C2C12 myoblasts, BMP/Smad signaling
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Introduction
The use of growth factors (GFs), such as bone/body
morphogenetic proteins (BMPs), in biomedical applications
is gaining importance over the last few years (Crouzier et al.,
2011; Kang et al., 2011). The lack of control over the amount
and release of GFs often leads to unwanted ectopic side effects
(Cheung and Phillips, 2006; Carragee et al., 2011). Especially
BMP-2 is already used for clinical applications, however, ectopic
bone formation has been observed (Rosen, 2009; Luca et al.,
2010). The immobilization of the GFs not only reduces ectopic
side effects but also proves to be more cost-efficient, since lower
amounts are required to obtain the desired local effect (Igwe
et al., 2012), while allowing for sustained presentation. Current
challenges in GF immobilization strategies are represented by (i)
achieving control over the amount of the immobilized molecule
and (ii) avoiding hindrance and interference with GF bioactivity
(Almodóvar et al., 2014).
Bone morphogenetic proteins were originally investigated for
their ability to regulate the formation of new bone. At the cellu-
lar level, BMPs direct and participate in different processes like
cell growth, apoptosis, differentiation, and migration (Sotobori
et al., 2006). BMPs bind the heteromeric receptor complexes
composed of type I and type II trans-membrane serine/threonine
kinase receptors (Miyazono et al., 2005; Sieber et al., 2009).
The activation of BMP receptors follows two different routes:
activation through preformed receptor complexes triggers a
Smad-dependent pathway, while complexes formed upon BMP
binding, the so-called BMP-induced signaling complexes, initiate
the activation of Smad-independent, p38-dependent pathways
(Nohe, 2001). The Smad-dependent signaling pathway is medi-
ated by endocytosis through functional clathrin-coated pits, while
Smad-independent pathways rely on the association of caveolae
with the receptor complexes (Hartung et al., 2006). Neverthe-
less, recent studies on the covalent immobilization of BMP-2
on surfaces indicated that BMP-2 internalization is not neces-
sary to trigger Smad 1/5 phosphorylation, suggesting that BMP-
dependent pathways might be already activated by GF binding to
the receptors (Pohl et al., 2012). Concerning the role of BMP in
cell migration, Smad-independent pathways have been observed
during BMP-2-mediated migratory effects. It has been reported
that BMP-2 can activate Cdc42/PAK/LIMK and p38/MK2/Hsp25
pathways independently (Gamell et al., 2008).
The extracellular matrix (ECM) is a meshwork of glycoproteins
and glycosaminoglycans, which provide structural and functional
integrity to tissues and organs. Amongst them, proteins such
as collagens and elastin, and glycoproteins such as fibronectin
(FN) are secreted and arranged in a fibrillar network by vari-
ous cell types, e.g., fibroblasts. FN is an abundant protein that
exists in two isoforms derived by alternative splicing: the solu-
ble plasma FN circulating in the blood and the insoluble cellu-
lar fibronectin (cFN), which is a component of the ECM. The
interactions between cells and FN are mediated by the cell-
binding motif RGD (arginine–glycine–aspartate) present in FN
(Hynes, 2009).
The ECM not only offers a support for adherent cells and reg-
ulates cell migration and differentiation (Yamaguchi et al., 2005),
but also presents a reservoir of GFs, which influence cell behavior
(Folkman et al., 1988; Taipale and Keski-Oja, 1997; Hynes,
2009). Proteoglycans, for example, bind fibroblast growth fac-
tors (FGFs) and vascular endothelial growth factors (VEGFs)
through their heparin chains (Hynes, 2009). ECM proteins that
do not contain such a pronounced sugar moiety are also able
to interact with GFs. For instance, FN, vitronectin, and collagen
type II have been shown to bind insulin-like GF-binding pro-
tein 5, hepatocyte GF, and transforming growth factor-β (TGF-
β) through specific binding sites, respectively (Xu et al., 2004;
Hynes, 2009). How GFs transduce information from the matrix
to the cells has not yet been conclusively clarified. Different
processes may occur for different GFs. One possibility is that
GFs interact with their receptors while they are bound to the
matrix and the ECM proteins act like cofactors. The release of
GFs upon degradation of the ECM due to injury or proteolytic
activity is also possible (Hynes, 2009). This results in the avail-
ability of GFs that can interact with their receptors at the cell
membrane independent of matrix components. This presenta-
tion mode offers a spatially and temporarily defined stimula-
tion with soluble GFs. Among them, it is known that the cells
secrete TGF-β as latency-associated peptide and it interacts with
fibrillins, incorporating into the ECM. Proteolytic degradation
or mechanical stretching by trans-membrane integrins releases
active TGF-βmolecules that bind to their respective TGF-β recep-
tors (Horiguchi et al., 2012).
Several approaches have been developed to immobilize GFs
to ECM components. For the delivery of BMP-2, new ECM
biomimetic systems have been reported, like inkjet printing of
BMP-2 patterns on fibrin substrates (Phillippi et al., 2008), soft
biopolymeric films presenting BMP-2 and hyaluronan hydrogels
(Patterson et al., 2010; Crouzier et al., 2011).
Combining the presentation of GFs with adhesive matrix
molecules offers the possibility to investigate the signaling and
crosstalk of different pathways involved in cell adhesion and
migration. An approach to better define, engineer, and ana-
lyze cell behavior is the fabrication of micropatterned adhe-
sive substrates, which present spatially defined ECM proteins
surrounded by non-adhesive molecules to backfill the area in
between (Jackman et al., 1999; Folch and Toner, 2000; White-
sides et al., 2001; Zheng et al., 2012). Additionally, to assess
and quantify complex cellular processes such as cell migration,
micropatterned stripes serve as excellent substrates to determine
migration speed and persistence (Petrie et al., 2009; Vedula et al.,
2012; Kasten et al., 2014).
In this study, we use microcontact printing tomanufacture FN-
coated surfaces (Csucs et al., 2003), which are further function-
alized with immobilized BMP-2 (iBMP-2) molecules. We report
on the influence of matrix-iBMP-2 on cell behavior. We chose
C2C12 myoblasts as in vitro system, since this cell line is an
established model for BMP-2 signaling. These cells fuse and form
contractile myotubes in the absence of BMP-2, but commit to the
osteogenic lineage upon BMP-2 exposure (Katagiri et al., 1994).
The phosphorylation and translocation of certain Smad proteins,
namely Smad 1/5/8, can be used as short-time read-out signal to
determine the bioactivity of BMP-2 (Sieber et al., 2009; Bragdon
et al., 2011).
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Materials and Methods
Preparation of Protein Solutions
Cellular fibronectin from human foreskin fibroblasts (Sigma-
Aldrich, St. Louis, MO, USA) was dissolved in sterile water
(1mg/ml) and dialyzed against PBS overnight using Dispo Bio-
dialyzer (MWCO 5 kDa, Sigma-Aldrich). Recombinant human
BMP-2 (rhBMP-2) derived from E. coli or CHO cells (355-
BEC/CF, 355-BM/CF, R&D Systems, Minneapolis, MN, USA)
was reconstituted in 1M NaCl (99.5% p.a. ACS ISO, Carl Roth,
Karlsruhe) in PBS to a concentration of 0.1mg/ml. NeutrAvidin
(NA; A2666, Life Technologies, Eugene, OR, USA) was dissolved
in PBS (5mg/ml).
Biotinylation of cFN and BMP-2
For protein biotinylation at free amines on the lysine side chains,
EZ-Link® NHS-PEG 12-biotin (Thermo Scientific, Rockford, IL,
USA) was dissolved in dry dimethyl sulfoxide (DMSO, Merck,
Darmstadt) to a concentration of 25mM. For labeling cFN, a 100-
fold molar excess of the linker was added to the protein. BMP-2
was labeled by adding a molar excess of 40, respectively. After-
wards, the solutions were incubated at room temperature (RT) for
1 hwhile shaking. Biotinylated cFN (cFN-biotin) or BMP-2 (BMP-
2-biotin) was purified overnight by dialysis against PBS or 1M
NaCl in PBS, respectively.
Fluorescent Conjugation of cFN
To visualize the micro patterned structures, cFN was fluores-
cently labeled. Atto-647N-NHS dye (ATTO-TEC GmbH, Siegen,
Germany) was dissolved in dry DMSO (10mg/ml) and added
to the cFN solution at a molar excess of 50. The solution was
incubated for 1 h while shaking. To remove unconjugated fluo-
rophores, themixture was dialyzed overnight against PBS yielding
fluorescently labeled cFN (cFN-647).
Photolithography and Microcontact Printing
Photolithography was used to produce the stamp master. Besides
the silanization step, all production steps were performed in a
clean room. A silicon wafer (Silicon Materials, Kaufering, Ger-
many) with a diameter of 5 cm was spin coated using the negative
photoresist SU-8 2002 (Microchem Corp., Newton, MA, USA)
according to the manufacturer’s instructions, yielding a thickness
of 2.7 µm. Then, a soft bake at 65°C for 2min and at 95°C
for another 2min was performed. Contact exposure through a
chrome mask, aligned by a custom-made vacuum mask holder,
was achieved with UV light (exposure time 1.9 s). Here, a mask
with a line width of 20 µm and spacing of 50 µm was used.
Following post-baking at 65°C for 3min, the resist was developed
inmr-DEV600developer (micro resist technologyGmbH,Berlin)
for 75 s. The stamp master was dried in a stream of nitrogen and
silanized with 1H1H2H2H-perfluorooctyltrichlorosilane (ABCR
GmbH & Co. KG, Karlsruhe, Germany) in a desiccator for 6 h.
Polydimethylsiloxane (PDMS) (Sylgard 184 Silicon Elastomer
Kit, Dow Corning, Seneffe, Belgium) was prepared according to
the manufacturer’s instructions and degassed under vacuum. One
milliliter of PDMS was poured into a Petri dish containing the
stamp master, degassed in vacuum, and subsequently cured at
65°C overnight. Afterwards, the PDMS was detached from the
stamp master, cut into 1 cm2 stamps, incubated in n-hexane for
30min, and sonicated in n-hexane for 5min to remove unreacted
monomers or crosslinkers.
For microcontact printing, the stamp surface was coated with
a mixture of 5 µl of cFN solution and 45 µl of PBS to obtain a
final concentration of 0.1mg/ml. As an alternative to the striped
structure, a homogeneous PDMS stamp was applied to produce
surfaces homogeneously covered with cFN. The solution was
incubated for 40min, after which the excess cFN was removed.
To minimize the amount of labeled cFN, a mixture consisting of
a ratio of 9:1 was incubated on the homogenous stamps with an
area of 1cm2. Glass coverslips (Carl Roth, Karlsruhe, Germany)
were cleaned with ethanol in an ultrasonic bath for 15min. Before
use, the glass slides were dried under a stream of nitrogen and
treated with oxygen plasma [GigaEtch, PVA TePla, Kirchheim
(München), Germany] at 0.4mbar and 150W for 10min. The
stamps were washed twice with 100 µl PBS, dried, and imme-
diately placed onto the glass for 30 s. The stamps were care-
fully removed from the coverslip and rinsed with PBS several
times. To prevent unspecific cell adhesion between the stripes, the
cFN-patterned surfaces were incubated with 100 µl of 0.1mg/ml
poly--lysine-g-poly (ethylene glycol) [PLL (20 kDa)-g(3.5)–PEG
(2 kDa), PLL–PEG, Surface Solutions, Switzerland] in HEPES
buffer for 30min (see Figure 1). To minimize the amount of
PLL–PEG per substrate, a piece of parafilm was used to ensure
an even coverage. Samples were then washed with PBS.
For soluble BMP-2 (sBMP-2), cFN and cFN-647 were added
in equal amount, while for the iBMP-2, the biotinylated cFN
(cFN-biotin) was used. For the immobilization of BMP-2, the
cFN-biotin micropatterned surfaces were incubated with NA at
a concentration of 0.01mg/ml in PBS for 30min followed by
washing with PBS. Afterwards, 50 µl of BMP-2-biotin in PBS with
a final concentration of 0.01 µg/µl was added for 1 h. Since the
stamped surfaces have an area of approximately 1 cm2, the max-
imal possible surface concentration was 0.5 µg/cm2. The biotin
linker consists of a 56Å PEG spacer that mediates the immobi-
lization of BMP-2 to NA and at the same time allows for a certain
degree of mobility due to its length.
Quartz Crystal Microbalance with Dissipation
Monitoring
The interaction between cFN-biotin, NA, and BMP-2-biotin from
E. coli cells was investigated using a quartz crystal microbal-
ance with dissipation monitoring (QCM-D). All QCM-D exper-
iments were performed in an E4 QCM-D from Q-Sense (Vaestra
Froelunda, Sweden) using open modules. The sensing elements
were silica-coated QCM-D crystals (QSX 303, Vaestra Froelunda,
Sweden) with a fundamental frequency of 4.95MHz. FN was
microcontact printed on the activated sensor using a flat stamp as
described in Section “Photolithography and Microcontact Print-
ing.” The passivation step was not necessary as only sensors
with a homogeneous layer of FN were prepared and the surfaces
were not used for cell experiments. Unspecific protein adsorption
was determined by direct comparison of adsorption processes
on sensors with and without NA-binding sides, e.g., for each
measurement, two sensors were functionalized with cFN and two
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FIGURE 1 | Procedure for microcontact printing. (A) A silicon wafer
was spin coated with a negative photoresist and treated according the
manufacturer’s instructions. Contact exposure through a chrome mask
with UV light and further processing resulted in the stamp master. PDMS
was poured on it, cured in an oven and was ready to use after a cleaning
step in n-hexane. (B) The stamp was incubated with a cFN solution and
the protein was adsorbed on the stamp surface. After a washing step,
the stamp was dried, inverted, and gently pressed on an oxygen
plasma-treated glass substrate whereby the protein structure was
transferred to the glass. A final incubation with PLL–PEG passivated the
surface in between the protein structure to prevent unspecific cell
adhesion.
sensors were coated with cFN-biotin. All samples were measured
in real-time under the same conditions. They were incubated
simultaneously and under the same conditions in NA and washed
before mounting the crystals in the QCM-D machine. The tem-
perature was adjusted to laboratory conditions and the stable
oscillation of the sensor was validated. Two-hundred microliters
of PBS were added in each chamber. The baseline was detected
for a few minutes. Next, the buffer was exchanged by 200 µl of
BMP-2-biotin (5 µg/cm2) for 1 h and afterwards the sensors were
washed with PBS until a final plateau was reached.
Enzyme-Linked Immunosorbent Assay
An enzyme-linked immunosorbent assay (ELISA) kit (DuoSet
ELISA, R&D Systems) was used to detect the BMP-2-biotin
release. Homogeneously stamped cFN-biotin surfaces were pre-
pared as described in Section “Photolithography and Microcon-
tact Printing,” in the presence of cFN-biotin or cFN without
biotinylation as negative control. The passivation step was omit-
ted, as in the QCM-D characterization. After incubation with
BMP-2-biotin CHO, the solutions containing the unbound pro-
teins were collected as well as the two washing solutions and the
overnight washing solutions at 4°C. The samples were treated
according to the manufacturer’s instructions. In brief, the 96-well
microplate was coated with capture antibody (part#840968 of
DuoSet ELISA, R&D Systems) and the samples were incubated
after a blocking step in reagent diluent (1% BSA in PBS, pH
7.2–7.4, 0.2 µm filtered). The detection antibody system [con-
sisting of biotinylated anti-BMP-2 mouse IgG and streptavidin
horseradish peroxidase (HRP)] was replaced with BMP-2 anti-
body directly coupled to HRP (part#892142 of Quantikine, BMP-
2 Immunoassay, R&D Systems) as it would interfere with the
detection of BMP-2-biotin. The absorbance was measured at
450 nm with a reference point at 570 using a plate reader (Infinite
M200, Tecan, Männedorf, Switzerland). All values were corrected
by the zero standard. Plotting the common logarithm of the
absorbance of averaged standard samples against the common
logarithm of the concentration generates a linear standard curve,
which was used for quantification of BMP-2 concentrations in
solution.
Cell Culture
Mouse C2C12myoblasts (ATCCCRL-1772) were cultured as sub-
confluent monolayers in Dulbecco’s modified Eagle’s medium
containing 4.5mg/ml glucose, 4mM -glutamine, and 1mM
sodium pyruvate (DMEM, 41966-029, Gibco Life Technologies,
Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine
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serum (FBS, S0115m, Biochrom AG, Berlin, Germany) and 1%
(v/v) penicillin/streptomycin (15140, Gibco) at 37°C and 5%CO2.
Indirect Immunofluorescent Staining and
Microscopy
The translocation of the Smad complex into the nucleus was
analyzed to investigate the short-term effect of BMP-2 E. coli
on myoblasts. Following serum starvation overnight, C2C12 cells
were seeded on homogeneously stamped cFN surfaces at a density
of 10,000 cells were seeded on a 20mm 20mm glass coverslip
and incubated for 30min to allow adhesion on the substrates.
Thereafter, 0.5 µg of BMP-2 was added to the medium (sBMP-
2), which was considered time point 0. All samples were fixed
after different time points (t0, 10, 30, 45, 60, 90min) with 4%
(w/v) paraformaldehyde (PFA) in PBS for 30min, rinsed with
PBS, and permeabilized with 0.1% (v/v) Triton-X-100 in PBS
(Sigma-Aldrich) for 5min. After blocking of unspecific binding
sites with 1% (w/v) BSA in PBS (1% BSA) for 30min, the surfaces
were incubated with the primary antibody anti-p-Smad 1/5 rab-
bit IgG (S463/465, clone 41D10, 9516S, Cell Signaling, Danvers,
MA, USA) at a dilution of 1:50 (according to the manufacturer’s
recommendation) in 1% BSA at RT for 1 h. After washing twice
with 1% BSA for 10min, the samples were incubated with the
respective secondary antibody Alexa Fluor 488® goat anti-rabbit
IgG (Life technologies, A11034) at a final concentration of 5 µg/ml
in 1% BSA as well as with Phalloidin-TRITC (0.2 µg/ml) at RT for
1 h and washed again twice with 1% BSA for 10min. Finally, the
samples were embedded in Mowiol (Sigma-Aldrich) containing
0.1% (v/v) DAPI for an additional staining of the nucleus. Stained
samples were imagedwith an upright wide fieldmicroscope (Leica
DM6000B, Leica Microsystems GmbH, Wetzlar, Germany) using
a 40 (HCX PL APO 40/0.85 CORR) objective lens. Image pro-
cessing was done using ImageJ software (version 1.48c, Rasband,
W.S., ImageJ, U.S. National Institutes of Health, Bethesda, MD,
USA)1. For analysis, a binary image of the nucleus and the cytosol
was produced. The obtained masks were used to quantify the
pSmad signal in these areas. To calculate the integrated densities,
the area was multiplied by the mean gray value. In addition, the
integrated density of the cytosol was divided by the integrated
density of the nucleus.
Since the presence of BMP-2 suppresses the differentiation
of C2C12 cells into myotubes and promotes osteogenic differ-
entiation, the myogenic phenotype was assessed by staining for
myosin heavy chain (MHC) in confluent cell monolayers. C2C12
cells were serum-starved overnight and cultured at a density of
5,000 cells/cm2 on homogeneous stamped cFN-biotin surfaces
under high serum conditions for 6 days at 37°C and 5% CO2.
Afterwards, cells were fixed and stained with anti-MHC mouse
IgG (MF20, DSHB, Iowa City, IA, USA) at a concentration of
2.3 µg/ml followed by Alexa Fluor® 488 goat anti-mouse IgG (Life
Technologies, A11001) and DAPI.
Western Blot
Short-term response was evaluated by western blot detection
of phosphorylated Smad 1/5. C2C12 cells were serum-starved
1http://imagej.nih.gov/ij/
overnight and 10,000 cells for each sample were seeded for 30min
at 37°C and 5% CO2 at a 1 cm2 homogeneously stamped cFN
surface with or without BMP-2 E. coli, as described in Section
“Enzyme-Linked Immunosorbent Assay.” After different time
points (0, 30, 45, 60min), cells were lysed in 2 Laemmli Buffer
(4% SDS, 20% Glycerol, 120mM Tris–HCl, pH 6.8, 200mM
DTT, 0.02% Bromphenolblue) at  80°C overnight and boiled
at 95°C for 5min. The total proteins homogenates were loaded
onto SDS-PAGE NuPAGE 4–12% Bis–Tris Gel, NuPAGE MES
Running Buffer (Novex, Life Technologies, Carlsbad, CA, USA)
and blotted into nitrocellulose membrane (GE Healthcare, Little
Chalfont, UK) in NuPAGE Transfer Buffer (Novex, Life Tech-
nologies, Carlsbad, CA, USA). The blots were blocked with 3%
milk (Carl Roth, Karlsruhe, Germany) in Tris-buffered saline with
0.1% Tween-20 (TBST, 50 nM Tris, pH 8.0, 150mM NaCl, 0.1%
Tween-20) at RT for 1 h and incubated at RT overnight in TBST
1% milk 1/1000 rabbit anti pSmad 1/5 (#9516, Cell Signaling,
Danvers, MA, USA) or 1 h in TBST 1% milk 1/2000 mouse anti
β-actin (A1978, Sigma-Aldrich, St. Louis, MO, USA). Blots were
then washed in TBST and incubated for 1 h in TBST 1% milk at
RT with HRP-conjugated secondary antibodies 1:5000 goat anti-
rabbit or goat anti-mouse (Santa Cruz Biotechnology, Heidelberg,
Germany). After washing, the membranes were incubated in ECL
prime western blotting detection reagent (GE Healthcare, Little
Chalfont, UK) and chemiluminescence detected using a LAS 3000
(Fujifilm, Tokyo, Japan).
Time-Lapse Video Microscopy and Analysis of
Cell Migration
Due to the dimension of the stripes, the cells were restricted
to only migrate in a linear manner. For migration experi-
ments, C2C12 cells were serum-starved overnight. Ten thousand
cells were seeded in 2ml medium at 37°C and 5% CO2 on
20mm 20mm glass surfaces with microcontact printed stripes.
Using an Olympus IX inverted microscope (Olympus, Hamburg,
Germany) with a Delta Vision RT system (Applied Precision Inc.,
Issaquah, WA, USA), 25 fields of view (603.03 µm 603.06 µm)
were recorded every 10min for at least 10 h using a 10 air objec-
tive lens (EC-PlanNeoFluor 10/0.3 Ph1, Zeiss, Oberkochen,
Germany) and detected with a cooled CCD camera (Photo-
metrics, Kew, Australia). Image acquisition was performed with
Resolve 3D (AppliedPrecision Inc.). Cell nuclei were tracked by
the ImageJ plugin manual tracking. Thus, the velocity of the cells
was analyzed and the net distances per hour were calculated and
also summed up to determine the total path lengths of the cells.
Statistic Analysis
All experiments were performed in at least two technical repeats.
Plots and histograms were generated with Microsoft Office Excel
2007, while box-plots were created with Prism 6 [version 6.04
(Trial), GraphPad]2. Values of the standard error of the mean
(SEM) were calculated from the raw data and were used for error
bars on graphs. Comparison between two sets of measures was
performed usingMann–Whitney test (two-tailed, 95% confidence
level: ***P< 0.001, **P< 0.01, *P< 0.1).
2http://www.graphpad.com/demos/
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org May 2015 | Volume 3 | Article 625
Hauff et al. Matrix-immobilized BMP-2 affects myoblast behavior
Results
BMP-2 is Successfully Immobilized on
Homogenous cFN-Coated Surfaces and is Not
Released After Immobilization
Prior to cell experiments, we characterized the surfaces by two
different methods, namely QCM-D and ELISA. To directly mon-
itor the binding of BMP-2 to cFN, we used QCM-D, which
detects the subsequent adsorption of mass to a quartz crystal,
resulting in a shift in the crystal’s resonance frequency. As already
described above “BMP-2 is Successfully Immobilized onHomoge-
nous cFN-Coated Surfaces and is Not Released After Immobi-
lization,” cFN/cFN-biotin was stamped on the QCM-D crystal.
After a washing step with PBS, NA was incubated on the crys-
tal followed by another washing step. Finally, BMP-2-biotin was
added to the system. Note the difference in adsorption of BMP-
2 in absence and presence of biotinylated cFN (Figure 2A). This
difference was especially visible during the washing step follow-
ing the initial adsorption of the protein. Due to its unspecific
interactions with materials, BMP-2 easily adsorbs to both surfaces
but it is released after washing with PBS if NA is not bound
to the biotinylated cFN. However, not all BMP-2 was removed
by the washing step, suggesting a persisting interaction of BMP-
2 with cFN at  2Hz. In the presence of biotinylated cFN, a
plateau was reached at  11Hz after washing for several minutes,
indicating the presence of a fraction of BMP-2 stably bound to the
surface.
With ELISA, we assessed the amount of iBMP-2 by measuring
the amount of the protein released in solution after 60min of incu-
bation and for each of the three washing steps (Figure 2B). Here,
cFN/cFN-biotin was homogenously stamped on glass substrates
and then incubated with NA and BMP-2-biotin. We derived the
amount of surface iBMP-2 by subtracting the amount of protein
detected in incubation and washing solutions from the initial
amount of BMP-2 in solution. Figure 2B depicts the three con-
ditions, namely cFN-biotin without NA and BMP-2, cFN-biotin
with BMP-2 butwithoutNA, and cFN-biotinwith BMP-2 andNA.
This corresponds to a surface concentration of iBMP-2, whichwas
approximately 520 ng/cm2.
Matrix-Immobilized BMP-2 Induces Smad 1/5
Phosphorylation and Prevents Myotube
Formation in C2C12
To investigate the bioactivity of iBMP-2, Smad 1/5 activation was
evaluated by western blotting and indirect immunofluorescent
staining. Cells were left to adhere on the surfaces for 30min
(indicated as time point 0) and then Smad 1/5 (pSmad 1/5) phos-
phorylation and nuclear translocation were monitored over time.
The initial 30-min incubation time is necessary since addition of
sBMP-2 is not sufficient to activate the Smad pathway in spreading
cells, because of rapid depletion of the GF from the medium (data
not shown). For the assessment of Smad phosphorylation, C2C12
myoblasts were seeded on surfaces coated with cFN in absence
of BMP-2 (negative control), whereas cells incubated in presence
of sBMP-2 in the media served as positive control. Cells were
lysed after 0, 30, 45, and 60min and the phosphorylation levels
and kinetics of Smad 1/5 were determined by western blotting.
Smad phosphorylation is detected only in cells exposed to sBMP-
2 and iBMP-2 after 30min, whereas only a faint band is present in
the samples without BMP-2 (Figure 3). iBMP-2 is able to trigger
Smad-dependent signaling and the levels of Smad phosphoryla-
tion are comparable to those observed when BMP-2 is added to
the media (sBMP-2).
Next, we monitored the shuttling of pSmad 1/5 from the
cytoplasm to the nucleus. Upon phosphorylation, Smad 1/5/8
forms the Smad complex, which acts as transcription factor in the
nucleus. C2C12 cells were first allowed to adhere to the surface
for 30min and then fixed after additional 10, 30, 45, and 60min
FIGURE 2 | (A) Frequency shifts of F7 measured by QCM-D. Measurements
of the adsorption of BMP-2 on QCM-D sensors coated with cFN-biotin
(black) and cFN without biotinylation (gray) followed by the binding of NA and
BMP-2-biotin. Here, the detail of the exchange from buffer to BMP-2-biotin
and the following washing step with PBS is shown in the graph. Note the
peaks represent the addition of the appropriate agent and the difference in
frequency shift corresponding to a higher mass adsorption on the sensor
with biotinylated cFN (black). (B) ELISA quantification of the release of
BMP-2 from the incubated surfaces. cFN-biotin surfaces in absence of
BMP-2 served as negative control. For the other two conditions, surfaces
exposed to BMP-2-biotin with and without NA as cross-linker were used.
The release was determined in the removed incubation solution as well as in
the three washing solutions [first washing step, second washing step, third
washing step (24 h)].
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FIGURE 3 |Western blot of Smad 1/5 phosphorylation in C1C12 cells.
Serum-starved cells were seeded on the surfaces for 30min (indicated as
time point 0) and lysed after 30, 45, and 60min. cFN surfaces serve as
control, sBMP-2 indicates cFN surfaces where BMP-2 has been added to
the media at the indicated durations. iBMP-2 indicates cFN surfaces with
crosslinked biotinylated-BMP-2. Non-stimulated cells adhering to the control
surfaces show basal Smad 1/5 phosphorylation signals, which are
time-independent, whereas cells stimulated with sBMP-2 and iBMP-2
present pronounced Smad phosphorylation. β-actin served as loading
control.
time (Figure 4). The quantification of the shuttling of the active
Smad complex from the cytoplasm to the nucleus shows a peak
at 30min in cells exposed to sBMP-2 that drops hereafter to
control levels (Figure 5). The nuclear translocation of pSmad 1/5
in cells on iBMP-2 instead presents a different pattern, with an
initial increase above the levels observed for the sBMP-2 at 10min,
followed by a drop at 30min. It should be noted that cells seeded
on iBMP-2 surfaces were exposed to BMP-2 upon surface contact.
After 45min, iBMP-2 leads again to an increased and sustained
accumulation of nuclear pSmad in comparison to the control
and the sBMP-2 groups. This increase could be explained by the
progression of cell-surface interactions, i.e., cells are exposed to
additional matrix-bound GFs.
C2C12 cells spontaneously fuse and form contractile mult-
inucleated myotubes after few days in culture. In presence of
osteoinductive GFs, such as BMP-2, this process is suppressed.
Here, we investigated the influence of iBMP-2 on myotube for-
mation in C2C12 cell cultured for 6 days on control surfaces
(cFN only, without BMP-2), in presence of BMP-2 added to
the culture media (sBMP-2) and on iBMP-2. MHC was stained
by indirect immunofluorescence as myotube-specific marker.
Figure 6 clearly depicts myotube formation in cells not exposed
to BMP-2 as indicated by the green staining. Both sBMP-2
and iBMP-2 successfully suppress myotube formation, as can
be seen in the reduced staining of MHC. Upon conjugation
with biotin, we observed a slight decrease in the bioactivity of
BMP-2 due to the biotinylation (see Figure S2 in Supplementary
Material).
Matrix-Immobilized BMP-2 Affects Cell Migration
on Microcontact Printed Structures
For the investigation of cell migration in presence of iBMP-2,
cFN was micropatterned in stripes, which served as adhesive and
directional guidance. The dimensions of the stripes were chosen
in accordance to the cell size and morphology; thus to ensure
that only single cells would migrate in a directed fashion and
would not bridge over several stripes, the stripes had a width
of 20 µm and spacing between the stripes 50 µm. The surface
between the cFN stripes was passivated with PLL–PEG to prevent
unspecific cell adhesion to the glass. Figure 7A shows an exam-
ple of a micropatterned glass surface. Fluorescently labeled cFN
mixed with unconjugated cFN at a ratio of 1:1 is microcontact
printed to visualize the integrity of the patterned stripes. The
stripes were inspected after each preparation step and remained
intact throughout the entire process (Figure S1 in Supplementary
Material). C2C12 myoblasts are able to adhere to the cFN pattern
and restricted to migrate on the stripes only, as can be seen in
Figure 7B.
As described in previous sections for the homogenously
stamped surfaces, BMP-2-biotin was immobilized on cFN/cFN-
biotin micropatterned stripes using NA as cross-linker. The
surface in between the cFN stripes was passivated to prevent
adhesion. As positive control, sBMP-2 was added to the cell media
while as negative control only cFN stripes without addition sBMP-
2 were used. Figure 8A shows a time course of cell migration
along micropatterned stripes in the three different conditions,
namely control, sBMP-2, and iBMP-2 (see also Video S1–S3 in
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FIGURE 4 | Indirect immunofluorescence of pSmad 1/5 at different
time points, from t0 to 90min. Cells were allowed to settle on the surface
for 30min (t0) to ensure proper adhesion. Note sBMP-2 was added to the
medium at t0 whereas cells seeded on iBMP-2-surfaces were exposed upon
surface contact. pSmad is depicted in the first column and appears green in
the merged images, nuclei are stained with DAPI (blue), pSmad (green), and
actin staining (red) were shown in a merged fluorescent channel (second
column). Scale bar 20 µm.
Supplementary Material). The arrows indicate the starting point
of one cell per condition over time. The velocities of the three con-
ditions are depicted in Figure 8B as box-plots, where the median
is displayed. Cells on all three conditions feature a similar veloc-
ity pattern with only slightly differing median values (control:
0.196 µm/min; sBMP-2: 0.265 µm/min; iBMP-2: 0.227 µm/min).
When analyzing the steadiness of cell migration by calculating
the net distances per hour, we found differences in the distance
pattern covered by the cells on the three conditions. Figure 8D
shows the migration profile divided into 1 h intervals. Cells on
sBMP-2 and iBMP-2 display a similar preference to higher dis-
tances, especially at later time points. In contrast, in absence of
BMP-2, cells show a rather constant behavior. Figure 8C sum-
marizes the total path length of the cells as box-plot taking all
net distances into account. Accordingly, cells upon BMP-2 expo-
sure tend to cover larger distances, as can be seen at the vary-
ing median values (control: 137 µm; sBMP-2: 245 µm; iBMP-2:
202 µm).
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FIGURE 5 | Quantification of pSmad translocation. Ratio of integrated densities for the pSmad signal in the cytosol and nucleus at the indicated time points.
***P<0.001, **P<0.01, *P<0.1.
FIGURE 6 | Long-term response of C2C12 cells after 6 days in the
presence of BMP-2. Indirect immunofluorescence was employed to stain the
myosin heavy subunit expressed in myotubes (green). The cell nuclei were
stained with DAPI (blue). Myotube formation was suppressed by sBMP-2 and
iBMP-2 but not for cultures of cells adhering to the control samples. Scale bar
100 µm.
Discussion
The study presented here illustrates the immobilization of BMP-
2, on cFN by employing the specific interaction between two
biotinylated proteins and NA as cross-linker. The immobilized
molecule retains its bioactivity since it activates short-term sig-
naling pathways, such as the Smad-dependent pathway as well
as long-term signaling pathways, such as suppression of myotube
formation. The amount of conjugated linkers per BMP-2molecule
was assumed using structural information of BMP-2 by consid-
ering only accessible lysine residues (11 and 15), which do not
interfere with receptor binding (Pohl et al., 2012). The less acces-
sible and less favorable lysine residues (73, 76, 97, and 101) might
be as well targeted during conjugation, although the orientation
of BMP-2 onto cFN might be not essential for maintaining
its activity.
After immobilization of the biotinylated BMP-2 and removal
of protein excess, the release from the surface was determined by
ELISA during two successive washing steps and after 24 h. The
amount of BMP-2 released during the washing steps were below
the detection limit. Themethods currently used for quantification
ofGFs in solution allowdetection as low as 0.25 ng. Thus, it cannot
be excluded that small amounts of BMP-2 might be released but
these are below the detection limit of the here employed ELISA.
Surface immobilization of BMP-2 via chemical linkers offers
the advantage of having a sustained presentation while reducing
the amount of the GF needed to trigger cell responses. Lagunas
et al. introduced a system to generate BMP-2 gradients, with
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FIGURE 7 | (A) Cell adhesion on microcontact printed stripes of 20 μm
width. A mixture of fluorescently labeled cFN-647 and cFN (left), and
cFN-647/cFN-biotin (right) was transferred to a glass slide previously
activated by oxygen plasma treatment. The spacing between the stripes is
50 µm. Scale bar 100 µm. (B) Single C2C12 cell migrating on 20 μm
cFN-biotin stripes in the presence of sBMP-2. The actin cytoskeleton
was stained with phalloidin-TRITC (green) and the nucleus with DAPI (blue),
whereas the cFN-647 stripe is labeled in red. Scale bar 20 µm.
a ligand density ranging from 1.4 to 2.3 pmol/cm2 (Lagunas
et al., 2010, 2013). Chemical surface gradients were established
by hydrolysis of PMMA. Due to the strong electrostatic interac-
tions of the BMP-2 molecule with biocompatible materials, other
approaches rely on mere physisorption or embedding in films
or gels such as PLL–HA as was shown by Crouzier et al. (2011)
and Almodóvar et al. (2014). They attached polyelectrolyte multi-
layer films to substrates by alternating the deposition of PLL and
hyaluronan. BMP-2 was loaded and entrapped within these films.
The concentration of the entrapped BMP-2 was approximately
700 ng/cm2, while only superficial molecules of the multilayer are
accessible for the cells.
Triggering Smad and non-Smad signaling pathways by iBMP-
2 pinpoint that ligand–receptor interaction rather than cellular
uptake of the GF is of particular importance. In fact, it has been
shown that the initial interactions at the plasma membrane are
sufficient for triggering Smad-dependent signaling (Bonor et al.,
2012) and that ligand internalization is not necessary for such
responses (Pohl et al., 2012). Smad signaling might occur inde-
pendently of endocytosis involving clathrin-coated pit but rather
require caveolin-mediated receptor internalization (Bonor et al.,
2012). In the current study, we cannot exclude that the GF alone
or the complex of GF–FN molecules are internalized over time.
At the same time, it could be possible that activated receptors
might traffic upon ligand recognition and binding, even without
internalization of the ligand. However, the mode of presentation
and delivery in vivo is still a matter of debate. Recently, binding
sites for GFs belonging to the TGF-β superfamily were verified
in several ECM glycoproteins. Also, other GF binding sites have
been found in ECM proteins, such as collagen and FN (Wijelath
et al., 2006; Hynes, 2009; Martino and Hubbell, 2010). In vivo, the
ECM increases the GFs’ bioavailability by serving as a reservoir.
GFs can be constitutively available or presented upon exogenous
or cellular action. Cryptic binding sites are exposed upon injury
or proteolytic processing leading to a rapid localized availability
of GFs. Also, tension forces (Zhu and Clark, 2014) affect GF
presentation. The juxtaposition with RGD-motives in the ECM
facilitates integrin-mediated cell adhesion and directly links GF
signaling to integrin signaling (Lin et al., 2011; Motegi et al., 2011;
Fujita et al., 2012).
The mode of GF presentation is essential for medical applica-
tions. Amongst other issues, the amount of bioactive factors is
a critical subject, since too high dosages bear the risks of side
effects and are cost ineffective. To evaluate theminimal amount of
BMP-2 necessary to trigger the desired cellular responses, BMP-2
has been immobilized on hexagonally ordered gold nanoparticle
arrays with varying interparticle distances (Schwab et al., 2015). In
this study, cells were exposed to theGF by sandwiching the BMP-2
bearing surfaces head first on the adherent cells. The cell interacts
with the GF at their apical side. In contrast to this approach,
we present simultaneously BMP-2 and FN, being both cues at
the basal side of the cell. Such mode of presentation effectively
triggered the Smad-dependent signaling as shown by Smad phos-
phorylation and nuclear shuttling of the Smad signaling complex
as well as by suppression of myotube formation. The activation of
the Smad-dependent signaling pathway as assessed here by Smad
translocation into the nucleus depicted a strong peak for sBMP-2
at around 30min followed by a decrease to control levels. iBMP-2
on the other hand exhibited overall lower values but sustained a
higher activity level during the time of observation. This behavior
might be explained by considering that sBMP-2 is only available
for a short period of time whereas in the case of iBMP-2, the
cells are constantly exposed to the GF while interacting with the
surface.
Here, we also investigated the non-transcriptional effect of
BMP-2 by assessing the influence of matrix-iBMP-2 on cell
migration mediated by cytoskeletal rearrangements. We chose
micropatterned stripes to restrict cell migration to only two
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FIGURE 8 | C2C12 migration on microcontact printed stripes. (A) Cells
were cultured in serum conditions on 20 µm cFN-biotin stripes. Within the first
10 h, the migration behavior upon sBMP-2, iBMP-2, and no BMP-2 exposure is
shown. All experiments were carried out in two technical repeats, with at least
25 cells per condition. Scale bar 50 µm. (B) Cell velocities upon different BMP-2
exposures on cFN-biotin stripes over a period of 10 h. *P<0.1. Horizontal bars
represent the median. (C) Averaged total path lengths of cells upon different
BMP-2 exposures. **P<0.01. Horizontal bars represent the median.
(D) Averaged net distances of cells in 1 h intervals. ****P<0.0001, ***P<0.001,
*P<0.1.
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directions. Previous studies have indicated that 1D topography
can mimic many aspects of fibrillar-oriented 3D cell-derived
ECMs. In both 1D and 3D, cell migration is a rapid and uniaxial
process, whereby external physical stimuli in the form of linear
topographical cues can regulate cell behavior (Doyle et al., 2009).
On single 1D micropatterned lines, myoblasts can align, polarize,
andmigrate directionally (Ghibaudo et al., 2009). Thus, these type
of patterned structures provide at the same time a simpler and
more representative system than 2D systems for understanding
3D fibrillar matrix regulation of the dynamics of cell adhesion
and signaling during cell migration (Cukierman et al., 2002).
However, in the systemwe presented here, the line width of 20 µm
is too large to observe quasi-3D migration patterns.
We show that during the first 4 h of observation, BMP-2 affects
cell migration regardless of the mode of BMP-2 presentation.
In fact, C2C12 cells tend to enhance their migratory behavior
as compared to the control. This observation is in agreement
with Hiepen et al. (2014), although we did not apply chemotactic
gradients.
While guidance cues provided by physical and structural prop-
erties of the ECM have emerged as key parameters for directing
cell migration, additional signals provided by gradients of sol-
uble chemoattractants are still considered as leading factors for
orchestrating cell movements (Tzvetkova-Chevolleau et al., 2008).
Hiepen et al. (2014) demonstrated the importance of BMP-2-
induced PI3K signaling for chemotaxis. Thus, the application of a
linear BMP-2 gradient resulted in an overall gain in directionality
of cell migration toward the source of BMP-2 as well as in an
increase of the covered distance. However, the nature of recep-
tor interaction and the mechanism determining polarity at the
plasma membrane level still needs to be elucidated. To this end,
our approach presented here on the immobilization of GFs to
ECM components can be further developed by establishing GF
gradients by microfluidics (Almodóvar et al., 2014).
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